EP

Enanta Pharmaceuticals

ENTA
NASDAQHealth Care

Recent Patents

enta
1 year ago

Filed a patent for "pharmaceutical compounds and compositions as c-kit kinase inhibitors" on Wed, August 9, 2023

New US Patent
enta
1 year ago

Filed a patent for "pharmaceutical compounds and compositions as c-kit kinase inhibitors" on Thu, December 7, 2023

New US Patent
enta
1 year ago

Filed a patent for "processes for the preparation of oxadiazolylamino benzodiazepine derivatives" on Wed, August 9, 2023

New US Patent
enta
1 year ago

Filed a patent for "pharmaceutical compounds and compositions as c-kit kinase inhibitors" on Tue, July 25, 2023

New US Patent
enta
1 year ago

Filed a patent for "compounds and compositions as c-kit kinase inhibitors" on Fri, July 14, 2023

New US Patent
enta
over 1 year ago

Filed a patent for "antiviral heterocyclic compounds" on Thu, April 6, 2023

New US Patent
enta
over 1 year ago

Filed a patent for "antiviral heterocyclic compounds" on Mon, October 2, 2023

New US Patent
enta
over 1 year ago

Filed a patent for "novel covalent inhibitors as antiviral agents" on Wed, December 21, 2022

New US Patent
enta
over 1 year ago

Filed a patent for "fused heterotetracyclic antiviral agents" on Mon, February 27, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "macrocyclic chalcone-amide derived antiviral agents" on Tue, November 15, 2022

New US Patent
enta
almost 2 years ago

Filed a patent for "macrocyclic chalcone-amide derived antiviral agents" on Thu, June 27, 2024

New US Patent
enta
almost 2 years ago

Filed a patent for "17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof" on Thu, May 11, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "fused heterobicyclic antiviral agents" on Mon, August 22, 2022

New US Patent
enta
almost 2 years ago

Filed a patent for "crystal forms of an anti-sars cov-2 agent" on Thu, October 6, 2022

New US Patent
enta
almost 2 years ago

Filed a patent for "novel spiropyrrolidine derived antiviral agents" on Thu, May 18, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "alkyne-containing antiviral agents" on Thu, May 25, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "spiropyrrolidine derived antiviral agents" on Thu, June 29, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "novel spiropyrrolidine derived antiviral agents" on Thu, May 25, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "saturated spirocyclics as antiviral agents" on Thu, June 8, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "heterocyclic antiviral agents" on Thu, June 8, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid" on Thu, July 27, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "processes for the preparation of substituted spirooxindole derivatives" on Thu, September 21, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "spiropyrrolidine derived antiviral agents" on Thu, October 19, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "antiviral heterocyclic compounds" on Thu, November 9, 2023

New US Patent
enta
almost 2 years ago

Filed a patent for "pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors" on Thu, December 28, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...